Fig. 3From: Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trialsRanked perceptions of UK Clinical Trials Units (CTUs) on the importance of barriers to adaptive designs (ADs) use in confirmatory trialsBack to article page